LAX.SH
APOLLO HOSPITALS ENTER. L·HOSPITALS 47.35·Healthcare Services Companies
Price
7,604.5
+0.05%52W Range
Market Cap
₹1,09,341.04 Cr
Traded: ₹317.55 Cr (0.29%) 0.0x
Free Float: ₹7,336.78 Cr (4.33% of FF traded)
Volume · 60D trend
4.19 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +11.0% | +14.0% | +15.0% | -- | -- | Accelerating |
| Sales | +16.0% | +14.0% | +14.0% | -- | +15.0% | Stable |
| Profit | +16.0% | +34.0% | +18.0% | -- | +39.0% | Stable |
| Return | +19.0% | +22.0% | +20.0% | +24.0% | -- | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,044 | 6,606 | 6,477 | 6,304 | 5,842 | 5,592 | 5,527 | 5,589 | 5,086 | 4,944 | 4,851 | 4,847 | 4,418 | 4,302 | 4,264 | 4,251 |
| Expenses | 5,951 | 5,594 | 5,512 | 5,362 | 4,990 | 4,822 | 4,765 | 4,774 | 4,410 | 4,303 | 4,237 | 4,219 | 3,909 | 3,814 | 3,780 | 3,699 |
| Operating Profit | 1,092 | 1,011 | 965 | 941 | 852 | 770 | 762 | 816 | 675 | 640 | 614 | 628 | 509 | 488 | 484 | 552 |
| Other Income | 62 | 54 | 48 | 61 | 54 | 72 | 69 | 44 | 49 | 37 | 29 | 26 | 34 | 20 | 35 | 23 |
| Interest | 120 | 119 | 113 | 110 | 108 | 115 | 110 | 118 | 116 | 119 | 113 | 111 | 106 | 95 | 100 | 93 |
| Depreciation | 235 | 224 | 219 | 218 | 215 | 211 | 185 | 184 | 177 | 190 | 167 | 163 | 167 | 159 | 153 | 155 |
| Profit Before Tax | 799 | 722 | 682 | 675 | 583 | 516 | 536 | 557 | 430 | 368 | 363 | 379 | 270 | 254 | 266 | 327 |
| Tax % | 24.0% | 24.0% | 24.0% | 27.0% | 24.0% | 20.0% | 29.0% | 29.0% | 27.0% | 30.0% | 30.0% | 34.0% | 36.0% | 43.0% | 39.0% | 35.0% |
| Net Profit | 610 | 551 | 516 | 494 | 441 | 414 | 379 | 396 | 316 | 258 | 254 | 249 | 173 | 146 | 162 | 213 |
| Exceptional Items | 0 | 0 | -19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 40.4 | 36.8 | 34.9 | 33.2 | 30.1 | 27.1 | 25.9 | 26.3 | 21.2 | 17.6 | 17.1 | 16.2 | 11.6 | 10.1 | 10.7 | 14.2 |
| Sales Growth (YoY) | -- | 18.1% | 17.2% | 12.8% | 14.9% | 13.1% | 13.9% | 15.3% | 15.1% | 14.9% | 13.8% | 14.0% | 16.4% | 21.3% | -- | -- |
| Sales Growth (QoQ) | -- | 2.0% | 2.7% | 7.9% | 4.5% | 1.2% | -1.1% | 9.9% | 2.9% | 1.9% | 0.1% | 9.7% | 2.7% | 0.9% | 0.3% | -- |
| OP Growth (YoY) | 28.2% | 31.3% | 26.6% | 15.3% | 26.2% | 20.3% | 24.1% | 29.9% | 32.6% | 31.1% | 26.9% | 13.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | 8.0% | 4.8% | 2.6% | 10.4% | 10.6% | 1.0% | -6.6% | 20.9% | 5.5% | 4.2% | -2.2% | 23.4% | 4.3% | 0.8% | -12.3% | -- |
| Profit Growth (YoY) | 34.0% | 36.0% | 39.0% | 26.0% | 42.0% | 54.0% | 52.0% | 63.0% | 83.0% | 76.0% | 60.0% | 14.0% | -47.0% | 60.0% | -33.0% | -18.0% |
| EPS Growth (YoY) | -- | 35.8% | 34.9% | 26.0% | 41.8% | 53.5% | 51.8% | 62.6% | 83.2% | 75.6% | 59.7% | 14.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 5.4% | 5.2% | 10.3% | 11.1% | 4.7% | -1.7% | 24.1% | 20.3% | 3.5% | 5.3% | 39.8% | 15.3% | -5.9% | -24.7% | -- |
| OP Margin | -- | 15.3% | 14.9% | 14.9% | 14.6% | 13.8% | 13.8% | 14.6% | 13.3% | 12.9% | 12.7% | 13.0% | 11.5% | 11.3% | 11.3% | 13.0% |
| Net Margin | -- | 8.3% | 8.0% | 7.8% | 7.5% | 7.4% | 6.9% | 7.1% | 6.2% | 5.2% | 5.2% | 5.1% | 3.9% | 3.4% | 3.8% | 5.0% |
| Material Cost % | -- | 52.0% | 52.0% | 51.0% | 52.0% | 52.0% | 52.0% | 51.0% | 52.0% | 51.0% | 52.0% | 51.0% | 51.0% | 52.0% | 52.0% | 51.0% |
| Employee Cost % | -- | 12.0% | 12.0% | 12.0% | 12.0% | 13.0% | 12.0% | 13.0% | 13.0% | 13.0% | 13.0% | 13.0% | 13.0% | 14.0% | 13.0% | 13.0% |
| P/S | 4.14 | 4.90 | 4.80 | 4.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 52.33 | 63.67 | 64.46 | 67.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 11.53 | 13.04 | 12.77 | 12.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50As per annexure enclosed
As per annexure enclosed
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve As per annexure enclosed
Certificate under Regulation 74(5) for the period ended 30th September 2026 is enclosed
as per annexure enclosed
Dear Sir, Sub : Submission of Updated Annual Report for FY 2025-26 We refer to the Annual Report of the Company for the financial year ended 31 March 2026, which was submitted to the ....
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosec
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve as per annexure enclosed
Certificate under Regulation 74(5) foe the period ended 30th June 2026 enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
As per annexure enclosed - Publication of advertisement - NCLT convened meetings
as per annexure enclosed
as per annexure enclosed
Notice convening meeting of unsecured creditors of the Company pursuant to the orders of National Company Law Tribunal, chennai
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
as per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
Update
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve As per annexure enclosed
Update - as per annexure enclosed
As per annexure enclosed
Annual Reports
15Credit Ratings
6Concalls
42Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025May 2025
31 May 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Apr 2024
30 Apr 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Jun 2021
30 Jun 2021Jun 2021
30 Jun 2021Nov 2020
30 Nov 2020Sep 2020
30 Sept 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Aug 2019
31 Aug 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017Apr 2017
30 Apr 2017Nov 2016
30 Nov 2016Feb 2016
29 Feb 2016Nov 2015
30 Nov 2015Held by ETFs
69 ETFs hold APOLLOHOSP · sorted by weight
Held by Mutual Funds
210 schemes hold APOLLOHOSP · sorted by weight